No evidence of disease activity after fingolimod treatment: A three-year real-world comparison of pre- and post-treatment outcomes in multiple sclerosis

Multiple Sclerosis and Related Disorders 2026

View at publisher

Authors: Ulvi Samadzade, Said Alizada, Can Caliskan, Orkhan Mammadov, Serkan Ozakbas

DOI: 10.1016/j.msard.2026.107044

Cited by: 1

References: 7

Fields of Study & Subjects

Sphingolipid Metabolism and Signaling Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders

References 7